Literature DB >> 4018796

A detailed analysis of chromosomal changes in heritable and non-heritable retinoblastoma.

J Squire, B L Gallie, R A Phillips.   

Abstract

Full cytogenetic analysis of 27 different retinoblastoma tumors is presented. Gross aneuploidy of chromosome arms 6p and 1q were very common, being observed in 15/27 and 21/27 tumors, respectively. However, we found that chromosome 13 was rarely missing: only 3/27 had a detectable monosomy affecting 13q14. Monosomy of chromosome 13 by small deletion or rearrangement was also not observed in any of 12 retinoblastoma tumor lines analyzed detail at the 300-400 chromosome band level. A novel observation in retinoblastoma was the discovery of non-random translocations at three specific breakpoints, 14q32 (4/12), 17p12 (5/12), and 10q25 (3/12). Genomic rearrangements similar to those described involving C-myc in Burkitt lymphoma 14q+ cells could not be demonstrated in the four 14q+ retinoblastoma lines using molecular techniques, and a probe mapping to the site implicated to have an activating role in lymphoma. These data suggest that there is a target for rearrangement at 14q32 but it is not the same sequence used in some Burkitt lymphomas. Two other breakpoints (2p24 and 8q24) coincided with the mapped position of cellular oncogenes, but also failed to show a molecular rearrangement with the oncogene probes. The breakpoints, 10q25 and 17p12, are constitutional fragile sites which may predispose these regions to act as acceptors of translocations in malignant cells. One line had double minute chromosomes, and was the only one of 16 (6%) tested with the N-myc probe which had an amplification. Different tumors from single patients with multifocal heritable retinoblastoma showed independent karyotype evolution. Unilateral non-heritable tumors exhibited a high level of karyotype stability throughout both in vivo and in vitro growth. The various common patterns of aneuploidy and translocations probably confer an early selective advantage to malignant cells, rather than induce malignant transformation.

Entities:  

Mesh:

Year:  1985        PMID: 4018796     DOI: 10.1007/bf00295364

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  42 in total

1.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

2.  Cloning and characterization of different human sequences related to the onc gene (v-myc) of avian myelocytomatosis virus (MC29).

Authors:  R Dalla-Favera; E P Gelmann; S Martinotti; G Franchini; T S Papas; R C Gallo; F Wong-Staal
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

3.  The role of gene dosage and genetic transpositions in carcinogenesis.

Authors:  G Klein
Journal:  Nature       Date:  1981-11-26       Impact factor: 49.962

4.  Cytogenetic analysis of retinoblastoma: evidence for multifocal origin and in vivo gene amplification.

Authors:  E Chaum; R M Ellsworth; D H Abramson; B G Haik; F D Kitchin; R S Chaganti
Journal:  Cytogenet Cell Genet       Date:  1984

5.  The characterization of high-resolution G-banded chromosomes of man.

Authors:  J J Yunis; J R Sawyer; D W Ball
Journal:  Chromosoma       Date:  1978-08-14       Impact factor: 4.316

6.  Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage.

Authors:  G M Brodeur; R C Seeger; M Schwab; H E Varmus; J M Bishop
Journal:  Science       Date:  1984-06-08       Impact factor: 47.728

7.  Similar chromosomal abnormalities in several retinoblastomas.

Authors:  L E Kusnetsova; E L Prigogina; H E Pogosianz; B M Belkina
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

8.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

9.  Break points in chromosome #1 abnormalities of 218 human neoplasms.

Authors:  V Brito-Babapulle; N B Atkin
Journal:  Cancer Genet Cytogenet       Date:  1981-11

10.  Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22.

Authors:  J Groffen; J R Stephenson; N Heisterkamp; A de Klein; C R Bartram; G Grosveld
Journal:  Cell       Date:  1984-01       Impact factor: 41.582

View more
  23 in total

1.  Constitutional deletions predisposing to retinoblastoma.

Authors:  M Janson; E Kock; M Nordenskjöld
Journal:  Hum Genet       Date:  1990-06       Impact factor: 4.132

2.  Additional chromosome 1q aberrations and der(16)t(1;16), correlation to the phenotypic expression and clinical behavior of the Ewing family of tumors.

Authors:  B Stark; C Mor; M Jeison; R Gobuzov; I J Cohen; Y Goshen; J Stein; S Fisher; S Ash; I Yaniv; R Zaizov
Journal:  J Neurooncol       Date:  1997-01       Impact factor: 4.130

3.  Transgenic models of retinoblastoma: what they tell us about its cause and treatment.

Authors:  D M Albert; A E Griep; P F Lambert; K A Howes; J J Windle; J G Lasudry
Journal:  Trans Am Ophthalmol Soc       Date:  1994

Review 4.  Understanding pRb: toward the necessary development of targeted treatments for retinoblastoma.

Authors:  Uma M Sachdeva; Joan M O'Brien
Journal:  J Clin Invest       Date:  2012-02-01       Impact factor: 14.808

5.  Multiple changes in oncogenes and tumor suppressor genes in human retinoblastoma.

Authors:  R O Howard
Journal:  Trans Am Ophthalmol Soc       Date:  1996

6.  The genetics of retinoblastoma, revisited.

Authors:  A Naumova; C Sapienza
Journal:  Am J Hum Genet       Date:  1994-02       Impact factor: 11.025

7.  Concordance between parental origin of chromosome 13q loss and chromosome 6p duplication in sporadic retinoblastoma.

Authors:  A Naumova; M Hansen; L Strong; P A Jones; D Hadjistilianou; D Mastrangelo; S Griegel; M F Rajewsky; J Shields; L Donoso
Journal:  Am J Hum Genet       Date:  1994-02       Impact factor: 11.025

8.  Cdh11 acts as a tumor suppressor in a murine retinoblastoma model by facilitating tumor cell death.

Authors:  Mellone N Marchong; Christine Yurkowski; Clement Ma; Clarellen Spencer; Sanja Pajovic; Brenda L Gallie
Journal:  PLoS Genet       Date:  2010-04-22       Impact factor: 5.917

9.  Molecular mechanism of retinoblastoma gene inactivation in retinoblastoma cell line Y79.

Authors:  E Y Lee; R Bookstein; L J Young; C J Lin; M G Rosenfeld; W H Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

10.  Comparative genomic hybridisation divides retinoblastomas into a high and a low level chromosomal instability group.

Authors:  J E van der Wal; M A J A Hermsen; H J P Gille; N Y N Schouten-Van Meeteren; A C Moll; S M Imhof; G A Meijer; J P A Baak; P van der Valk
Journal:  J Clin Pathol       Date:  2003-01       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.